Voyager Therapeutics (VYGR) News Today → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free VYGR Stock Alerts $8.40 +0.26 (+3.19%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31 at 1:28 AM | marketbeat.comVoyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Rating of "Moderate Buy" from BrokeragesShares of Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Free Report) have received a consensus rating of "Moderate Buy" from the seven analysts that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and five have given a buy ratingMay 16, 2024 | finance.yahoo.comVoyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s DiseaseMay 16, 2024 | globenewswire.comVoyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer's DiseaseMay 15, 2024 | marketbeat.comVoyager Therapeutics (NASDAQ:VYGR) Receives Outperform Rating from OppenheimerOppenheimer restated an "outperform" rating and set a $18.00 target price on shares of Voyager Therapeutics in a report on Wednesday.May 15, 2024 | benzinga.comLatest News for Voyager Therapeutics Stock (NASDAQ:VYGR)May 14, 2024 | finanznachrichten.deVoyager Therapeutics, Inc.: Voyager Therapeutics Reports First Quarter 2024 Financial and Operating ResultsMay 14, 2024 | markets.businessinsider.comPositive Outlook for Voyager Therapeutics: Buy Rating Affirmed Amid Pipeline Progress and Strong Financial PositionMay 14, 2024 | msn.comVoyager Therapeutics, Inc. (NASDAQ:VYGR) Q1 2024 Earnings Call TranscriptMay 14, 2024 | finance.yahoo.comQ1 2024 Voyager Therapeutics Inc Earnings CallMay 14, 2024 | marketbeat.comWedbush Trims Voyager Therapeutics (NASDAQ:VYGR) Target Price to $8.00Wedbush decreased their price target on shares of Voyager Therapeutics from $10.00 to $8.00 and set a "neutral" rating for the company in a report on Tuesday.May 14, 2024 | finance.yahoo.comVoyager Therapeutics Inc (VYGR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 13, 2024 | sfgate.comVoyager Therapeutics: Q1 Earnings SnapshotMay 13, 2024 | msn.comVoyager Therapeutics GAAP EPS of -$0.20 beats by $0.24, revenue of $19.5M beats by $10.02MMay 13, 2024 | globenewswire.comVoyager Therapeutics Reports First Quarter 2024 Financial and Operating ResultsMay 10, 2024 | msn.comVoyager 1 was in crisis in interstellar space. NASA wouldn’t give up.May 8, 2024 | msn.comThe Invincible - Official Voyager Update TrailerMay 8, 2024 | msn.com8 Coolest Starships in Star Trek: VoyagerMay 8, 2024 | finance.yahoo.comVoyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual MeetingMay 7, 2024 | marketbeat.comVoyager Therapeutics (VYGR) to Release Quarterly Earnings on MondayVoyager Therapeutics (NASDAQ:VYGR) will be releasing earnings after the market closes on Monday, May 13, Zacks reports.May 6, 2024 | finance.yahoo.comVoyager Therapeutics' (NASDAQ:VYGR) three-year earnings growth trails the splendid shareholder returnsMay 6, 2024 | globenewswire.comVoyager Therapeutics Announces First Quarter 2024 Conference Call and WebcastApril 30, 2024 | msn.comScientist Warns That NASA’s Voyager Probes Are “Dodging Bullets Out There”April 29, 2024 | msn.com7 Star Trek: Voyager Alien Villains Worse Than Discoverys BreenApril 27, 2024 | msn.comSilent no more: NASA hears from Voyager 1, the most distant spacecraftApril 26, 2024 | yahoo.comInside NASA's 5-month fight to save the Voyager 1 mission in interstellar spaceApril 25, 2024 | marketbeat.comVoyager Therapeutics (NASDAQ:VYGR) Stock Price Down 3.7%Voyager Therapeutics (NASDAQ:VYGR) Shares Down 3.7%April 24, 2024 | msn.comNASA re-establishes communication with Voyager 1 interstellar spacecraft that went silent for monthsApril 24, 2024 | forbes.comNASA Celebrates As 1977’s Voyager 1 Phones Home At LastApril 24, 2024 | usatoday.comVoyager 1 had a problem. Here's how NASA fixed it from 15 billion miles away.April 24, 2024 | abcnews.go.comNASA's Voyager 1 sending readable data back to Earth for 1st time in 5 monthsApril 24, 2024 | msn.comAfter months of silence, Voyager 1 has returned NASA’s callsApril 23, 2024 | msn.comNASA’s Voyager 1 probe is finally making sense againApril 23, 2024 | yahoo.comVoyager-1 sends readable data again from deep spaceApril 23, 2024 | barrons.comNASA's Voyager 1 Phones Home After MonthsApril 23, 2024 | msn.comVoyager 1 sending data to Earth for 1st time in 5 monthsApril 22, 2024 | yahoo.comNASA's Voyager 1 Is Finally Making Sense After Months of Transmitting GibberishApril 22, 2024 | msn.comNASA's Voyager 1 resumes sending engineering updates to EarthApril 22, 2024 | globenewswire.comVoyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual MeetingApril 18, 2024 | reuters.comLouis Vuitton holds 'Voyager' fashion show in ShanghaiApril 18, 2024 | yahoo.comNicolas Ghesquière’s First Voyager Show Was All About Chinese YouthApril 18, 2024 | marketbeat.comVoyager Therapeutics (NASDAQ:VYGR) Stock Price Up 1.4%Voyager Therapeutics (NASDAQ:VYGR) Trading Up 1.4%April 17, 2024 | msn.comNASA tries to jog Voyager 1's memory from 15 billion miles awayApril 17, 2024 | marketbeat.comVoyager Therapeutics (NASDAQ:VYGR) Shares Down 2.9% Voyager Therapeutics (NASDAQ:VYGR) Trading Down 2.9%April 17, 2024 | markets.businessinsider.comOptimistic Buy Rating for Voyager Therapeutics Amid Strong Pipeline and Strategic PartnershipsApril 16, 2024 | marketbeat.comVoyager Therapeutics (NASDAQ:VYGR) Trading Down 1.1%Voyager Therapeutics (NASDAQ:VYGR) Stock Price Down 1.1%April 16, 2024 | globenewswire.comVoyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone PaymentApril 15, 2024 | marketbeat.comVoyager Therapeutics (NASDAQ:VYGR) Shares Down 2.8% Voyager Therapeutics (NASDAQ:VYGR) Trading Down 2.8%April 12, 2024 | msn.comDS9 Predicted Star Trek: Voyager’s Hologram Doctor Fighting For His RightsApril 12, 2024 | marketbeat.comVoyager Therapeutics (NASDAQ:VYGR) Stock Price Down 1.6%Voyager Therapeutics (NASDAQ:VYGR) Stock Price Down 1.6%April 11, 2024 | marketbeat.comVoyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Free Report) have received an average recommendation of "Moderate Buy" from the seven research firms that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and six have given a buy rat Get Voyager Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter. Email Address On June 10, Nvidia makes its next big move (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.” Click here to find out who they are. VYGR Media Mentions By Week VYGR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VYGR News Sentiment▼1.580.78▲Average Medical News Sentiment VYGR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VYGR Articles This Week▼26▲VYGR Articles Average Week Get Voyager Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Adverum Biotechnologies News bluebird bio News CASI Pharmaceuticals News Sana Biotechnology News Neumora Therapeutics News Vir Biotechnology News Ginkgo Bioworks News Cullinan Therapeutics News Tarsus Pharmaceuticals News 4D Molecular Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VYGR) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyager Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
